BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15289878)

  • 1. The interaction of tenascin-C with fibronectin modulates the migration and specific metalloprotease activity in human mesothelioma cell lines of different histotype.
    Giuffrida A; Scarpa S; Birarelli P; Modesti A
    Int J Oncol; 2004 Sep; 25(3):745-50. PubMed ID: 15289878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of fibrillar Tenascin-C in metastatic pancreatic cancer.
    Chen J; Chen Z; Chen M; Li D; Li Z; Xiong Y; Dong J; Li X
    Int J Oncol; 2009 Apr; 34(4):1029-36. PubMed ID: 19287959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMMPRIN modulates migration and deposition of TN-C in oral squamous carcinoma.
    Dang D; Atakilit A; Ramos DM
    Anticancer Res; 2008; 28(4B):2049-54. PubMed ID: 18751374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenascin and fibronectin expression in human mesothelial cells and pleural mesothelioma cell-line cells.
    Kinnula VL; Linnala A; Viitala E; Linnainmaa K; Virtanen I
    Am J Respir Cell Mol Biol; 1998 Sep; 19(3):445-52. PubMed ID: 9730872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac extracellular matrix tenascin-C deposition during fibronectin degradation.
    Ma S; Yang D; Li D; Tang B; Sun M; Yang Y
    Biochem Biophys Res Commun; 2011 Jun; 409(2):321-7. PubMed ID: 21586275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does glycosylation of melanoma cells influence their interactions with fibronectin?
    Litynska A; Przybylo M; Pochec E; Kremser E; Hoja-Lukowicz D; Sulowska U
    Biochimie; 2006 May; 88(5):527-34. PubMed ID: 16380202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase.
    Zagzag D; Shiff B; Jallo GI; Greco MA; Blanco C; Cohen H; Hukin J; Allen JC; Friedlander DR
    Cancer Res; 2002 May; 62(9):2660-8. PubMed ID: 11980665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: comparison with fibronectin.
    Oyama F; Hirohashi S; Shimosato Y; Titani K; Sekiguchi K
    Cancer Res; 1991 Sep; 51(18):4876-81. PubMed ID: 1716516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines.
    Wilson KE; Bartlett JM; Miller EP; Smyth JF; Mullen P; Miller WR; Langdon SP
    Br J Cancer; 1999 May; 80(5-6):685-92. PubMed ID: 10360644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast.
    Yoshida T; Matsumoto E; Hanamura N; Kalembeyi I; Katsuta K; Ishihara A; Sakakura T
    J Pathol; 1997 Aug; 182(4):421-8. PubMed ID: 9306963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-type 1 matrix metalloproteinase modulates focal adhesion stability and cell migration.
    Takino T; Watanabe Y; Matsui M; Miyamori H; Kudo T; Seiki M; Sato H
    Exp Cell Res; 2006 May; 312(8):1381-9. PubMed ID: 16473349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts.
    Tremble P; Chiquet-Ehrismann R; Werb Z
    Mol Biol Cell; 1994 Apr; 5(4):439-53. PubMed ID: 7519905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenascin-C in the extracellular matrix promotes the selection of highly proliferative and tubulogenesis-defective endothelial cells.
    Alves TR; da Fonseca AC; Nunes SS; da Silva AO; Dubois LG; Faria J; Kahn SA; Viana NB; Marcondes J; Legrand C; Moura-Neto V; Morandi V
    Exp Cell Res; 2011 Sep; 317(15):2073-85. PubMed ID: 21740900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment.
    Yang C; Zeisberg M; Lively JC; Nyberg P; Afdhal N; Kalluri R
    Cancer Res; 2003 Dec; 63(23):8312-7. PubMed ID: 14678990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific processing of tenascin-C by the metalloprotease meprinbeta neutralizes its inhibition of cell spreading.
    Ambort D; Brellier F; Becker-Pauly C; Stöcker W; Andrejevic-Blant S; Chiquet M; Sterchi EE
    Matrix Biol; 2010 Jan; 29(1):31-42. PubMed ID: 19748582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical assessment of fibronectin and tenascin and their integrin receptors alpha5beta1 and alpha9beta1 in gastric and colorectal cancers with lymph node and liver metastases.
    Gulubova M; Vlaykova T
    Acta Histochem; 2006; 108(1):25-35. PubMed ID: 16430945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrins alpha5beta1, alphavbeta1, and alphavbeta6 collaborate in squamous carcinoma cell spreading and migration on fibronectin.
    Koivisto L; Grenman R; Heino J; Larjava H
    Exp Cell Res; 2000 Feb; 255(1):10-7. PubMed ID: 10666329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Native and fragmented fibronectin oppositely modulate monocyte secretion of MMP-9.
    Marom B; Rahat MA; Lahat N; Weiss-Cerem L; Kinarty A; Bitterman H
    J Leukoc Biol; 2007 Jun; 81(6):1466-76. PubMed ID: 17327485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenascin-C in peripheral nerve morphogenesis.
    Chiquet M; Wehrle-Haller B
    Perspect Dev Neurobiol; 1994; 2(1):67-74. PubMed ID: 7530145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta regulates the expression of fibronectin and tenascin in BEAS 2B human bronchial epithelial cells.
    Linnala A; Kinnula V; Laitinen LA; Lehto VP; Virtanen I
    Am J Respir Cell Mol Biol; 1995 Nov; 13(5):578-85. PubMed ID: 7576694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.